Healthcare -
Biotechnology - NASDAQ - US
$ 34.545
-0.619 %
$ 2.68 B
Market Cap
111.44
P/E
VCYT - COST OF REVENUE
Cost of Revenue VCYT - Veracyte, Inc.
113 M
LAST VALUE
23.19%
2 YEAR CAGR
27.83%
5 YEAR CAGR
24.51%
10 YEAR CAGR